Condition
Ampulla of Vater Adenoma
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Unknown2
Completed1
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07199127Recruiting
Duodenal Polyposis Classification in FAP
NCT06648746Not Yet RecruitingPrimary
Predictors of Therapeutic Success and Adverse Events in Endoscopic Ampullectomy
NCT05690412Unknown
Efficacy and Safety of Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms.
NCT02165852Phase 3CompletedPrimary
Comparison on the Efficacy of Endoscopic Snare Papillectomy With or Without Submucosal Injection
NCT01737463Phase 4UnknownPrimary
Prophylactic Pancreatic Duct Stent Placement After ESP of Major Papillary Tumors; Prospective, Randomized Study
Showing all 5 trials